What triggers the breakdown of B cell-mediated tolerance that leads to pathogenic anti-AQP4 antibody production in NMOSD?

While the study identifies B cells as tolerance orchestrators, the environmental or genetic factors that disrupt this protective mechanism in neuromyelitis optica patients remain unclear. This knowledge gap limits our ability to predict disease onset and develop preventive strategies.

Gap type: open_question Source paper: B cells orchestrate tolerance to the neuromyelitis optica autoantigen AQP4. (2024, Nature, PMID:38383779)

{“resolution_pipeline”: “scidex.atlas.gap_closure_pipeline”, “task_id”: “f4f7b129-0f43-4c84-abd8-20d4e701842d”, “evaluated_at”: “2026-04-28T19:10:38.309837+00:00”, “resolution_summary”: “Resolved by hypothesis h-c883a9eb10: Combine Anti-AQP4 Autoimmunity Control with Astrocyte-Endfoot Repair in NMOSD. Supporting evidence includes debate sess_SDA-2026-04-13-gap-pubmed-20260410-142329-c1db787b_20260413-202651.”, “match_counts”: {“hypothesis_matches”: 1, “debate_matches”: 5, “paper_matches”: 0}, “hypothesis_matches”: [{“id”: “h-c883a9eb10”, “title”: “Combine Anti-AQP4 Autoimmunity Control with Astrocyte-Endfoot Repair in NMOSD”, “score”: 0.334, “reason”: “16 token overlaps; entity overlap: aqp4, nmosd”, “analysis_id”: “SDA-2026-04-07-gap-pubmed-20260406-041445-7e1dc0b2”, “target_gene”: “AQP4, IL6R, CD19, C5”, “target_pathway”: null, “disease”: “neurodegeneration”, “composite_score”: 0.63, “confidence_score”: 0.6, “status”: “proposed”, “pubmed_evidence_ids”: [“34486379”, “36933107”, “PMC8248139”]}], “debate_matches”: [{“id”: “sess_SDA-2026-04-13-gap-pubmed-20260410-142329-c1db787b_20260413-202651”, “title”: “The title suggests B cells actively maintain tolerance to AQP4, but the specific molecular mechanisms by which B cells prevent anti-AQP4 autoimmunity are not detailed. Understanding this tolerance mechanism is critical for developing targeted therapies for neuromyelitis optica.\n\nGap type: unexplained_observation\nSource paper: B cells orchestrate tolerance to the neuromyelitis optica autoantigen AQP4. (2024, Nature, PMID:38383779)”, “score”: 0.629, “reason”: “13 token overlaps; entity overlap: aqp4, pmid”, “analysis_id”: “SDA-2026-04-13-gap-pubmed-20260410-142329-c1db787b”, “quality_score”: 0.79, “status”: “completed”, “target_artifact_id”: null, “target_artifact_type”: null}, {“id”: “sess_SDA-2026-04-13-gap-pubmed-20260410-142329-c1db787b_20260413-221849”, “title”: “The title suggests B cells actively maintain tolerance to AQP4, but the specific molecular mechanisms by which B cells prevent anti-AQP4 autoimmunity are not detailed. Understanding this tolerance mechanism is critical for developing targeted therapies for neuromyelitis optica.\n\nGap type: unexplained_observation\nSource paper: B cells orchestrate tolerance to the neuromyelitis optica autoantigen AQP4. (2024, Nature, PMID:38383779)”, “score”: 0.629, “reason”: “13 token overlaps; entity overlap: aqp4, pmid”, “analysis_id”: “SDA-2026-04-13-gap-pubmed-20260410-142329-c1db787b”, “quality_score”: 0.66, “status”: “completed”, “target_artifact_id”: null, “target_artifact_type”: null}, {“id”: “sess_SDA-2026-04-08-gap-pubmed-20260406-062222-cc3bcb47”, “title”: “While the abstract mentions identifying subcellular roles of protein interactions, the mechanistic principles governing how interaction networks specify subcellular function remain unclear. This knowledge gap limits our ability to predict how disease mutations disrupt cellular compartmentalization in neurons.\n\nGap type: open_question\nSource paper: A reference map of the human binary protein interactome. (2020, Nature, PMID:32296183)”, “score”: 0.492, “reason”: “14 token overlaps; entity overlap: pmid”, “analysis_id”: “SDA-2026-04-08-gap-pubmed-20260406-062222-cc3bcb47”, “quality_score”: 0.95, “status”: “completed”, “target_artifact_id”: null, “target_artifact_type”: null}, {“id”: “sess_SDA-2026-04-07-gap-pubmed-20260406-041445-7e1dc0b2_task_9aae8fc5”, “title”: “While the abstract identifies AQP4 as a ‘potential and promising target’ and mentions it could provide ‘new therapeutic alternatives,’ the specific approaches for therapeutic modulation of AQP4 function are not defined. This represents a critical translational gap for moving from mechanistic understanding to clinical intervention.\n\nGap type: open_question\nSource paper: Aquaporin-4 in glymphatic system, and its implication for central nervous system disorders. (2023, Neurobiol Dis, PMID:36796590)”, “score”: 0.456, “reason”: “8 token overlaps; entity overlap: aqp4, pmid”, “analysis_id”: “SDA-2026-04-07-gap-pubmed-20260406-041445-7e1dc0b2”, “quality_score”: 0.76, “status”: “completed”, “target_artifact_id”: null, “target_artifact_type”: null}, {“id”: “sess_SDA-2026-04-07-gap-pubmed-20260406-041445-ce0abc1e_task_73907230”, “title”: “The abstract states that AQP4 ‘is part of the pathogenesis’ of CNS disorders and shows ‘notable variability’ in these conditions, but the precise causal mechanisms linking AQP4 alterations to disease development remain unexplained. Understanding these mechanisms is critical for developing AQP4-targeted therapeutics.\n\nGap type: unexplained_observation\nSource paper: Aquaporin-4 in glymphatic system, and its implication for central nervous system disorders. (2023, Neurobiol Dis, PMID:36796590)”, “score”: 0.415, “reason”: “7 token overlaps; entity overlap: aqp4, pmid”, “analysis_id”: “SDA-2026-04-07-gap-pubmed-20260406-041445-ce0abc1e”, “quality_score”: 0.757, “status”: “completed”, “target_artifact_id”: null, “target_artifact_type”: null}], “paper_matches”: []}